GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon. The pharma giant sold 300m ordinary shares in Haleon in a placing at 326p each.

GSK will now hold around 385m ordinary shares in Haleon, which represents a stake of about 4.2%.

GSK and Pfizer - which has a 32% interest in Haleon - have both agreed not to sell any further shares in Haleon for 60 days.

Haleon was spun out from GlaxoSmithKline in 2019 and created through the merger of GSK and Pfizer's consumer healthcare business.